Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used)

Last updated: March 26, 2024
Sponsor: Methodist Health System
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemorrhage

Treatment

Pelvic Angioembolization

Clinical Study ID

NCT06336889
092.TRA.2018.D
  • Ages > 18
  • All Genders

Study Summary

The investigator's propose a multicenter prospective observational study to investigate the use of embolization in patients with negative angiogram and to ascertain the optimal level of treatment when the angiogram is positive; non-selective vs. selective embolization.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • • All blunt trauma patients undergoing angiography for pelvic fracture associatedhemorrhage

Exclusion

Exclusion Criteria:

  • • Pregnant patients
  • Patients < 18 years old
  • Patients undergoing angiography greater than 24 hours from arrival

Study Design

Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Pelvic Angioembolization
Phase:
Study Start date:
October 26, 2017
Estimated Completion Date:
October 31, 2024

Study Description

The investigator's propose a multicenter prospective observational study to investigate the use of embolization in patients with negative angiogram and to ascertain the optimal level of treatment when the angiogram is positive; non-selective vs. selective embolization. The investigator's will divide patients into groups based on positive or negative angiogram. Within each group the investigator's will compare those embolized and level of embolization. All blunt trauma patients undergoing angiography for pelvic fracture associated hemorrhage will be eligible for the study. Demographic, physiologic, operative, and post-operative data will be collected including blood product resuscitation, classification and management of pelvic fracture, associated injuries, angiographic details, complications, outcomes and overall injury burden. The study population will be stratified based on presence of arterial hemorrhage on initial angiogram (positive or negative angiogram) and then further stratified based on performance of embolization. NSE will be defined as embolization of the main internal iliac artery, either unilaterally or bilaterally and SE as any embolization distal to the main internal iliac artery. Bivariable and multivariable analyses will be performed to determine differences in pelvic hemorrhage as measured by transfusion necessity and quantity of products required, complications and to identify independent risk factors for outcome variables. A power analysis was performed based off of thromboembolic complication difference in selective vs. non selective embolization and then again with blood transfusion requirement difference in embolized vs. not embolized for those who have no evidence of arterial bleeding on angiogram (IE the two questions the investigator's are trying to answer).The investigator's plan to complete the data collection and analysis by 1/1/2019.

Connect with a study center

  • Methodist Dallas Medical Center

    Dallas, Texas 75201
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.